Disclosure 0001918845-26-000031-1

SEC FORM 4

$5,459.16

Avalo Therapeutics, Inc. (AVTX)

Acquisition (code M) of 679 shares at $8.04 per share.

Reporting Person Doyle Mittie · Officer Title Chief Medical Officer · Transaction Code M

Traded Aug 28, 2026 · Disclosed Sep 1, 2026

Source: SEC Form 4 · 0001918845-26-000031 · filed 2026-09-01 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Avalo Therapeutics, Inc. (AVTX)." Disclosed 2026-09-01. https://desqlong.com/cards/0001918845-26-000031-1 (retrieved 2026-09-26).